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a b s t r a c t
Treacher Collins syndrome (TCS) is an autosomal dominant disorder of craniofacial deve-
lopment. The syndrome is characterized by a similar phenotype: micrognathia, microtia,
midface hypoplasia, cleft lip and palate. The estimated incidence rate is 1/50 000 live
births. Treacher Collins syndrome is mostly caused by mutations in the TCOF1 gene,
which encodes the serine/alanine-rich protein Treacle. TCS can also be caused by muta-
tions in the POLR1C and POLR1D genes. About 70% of recognized mutations of the TCOF1
gene in TCS patients are deletions, which lead to formation of a termination codon and
shortening of the protein. The aim of the study was to search for mutations in TCOF1
gene causing a Treacher Collins syndrome. Examined DNA was isolated from peripheral
blood leukocytes of the male patient born at 38 weeks of gestation and his healthy
parents. The PCR products were subjected to MSSCP analysis. The PCR products were
puriﬁed on the DNA GelOut columns followed by direct sequencing. A novel, heterozy-
gous deletion c.1978delC was detected in one patient with typical facial symptoms of
Treacher Collins syndrome. The patient's parents were tested and no mutation was
observed, indicating de novo origin of the examined mutation. The c.1978delC deletion
causes premature termination of translation at 677aa. The ﬁnding will facilitate precise
diagnosis of the patient and will extend knowledge on the pathogenesis of TCS.
© 2014 Polish Pediatric Society. Published by Elsevier Urban & Partner Sp. z o.o. 
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Treacher Collins syndrome (TCS) [1] is an autosomal domi-
nant disorder affecting differentiation of the ﬁrst and the
second pharyngeal arches [2]. This syndrome occurs with an
estimated prevalence of 1 in 50 000 live births. In 60% of
cases the disease is caused by de novo mutations; however,
family history was conﬁrmed in 40% of patients [3].
Patients with Treacher Collins syndrome are characteri-
zed by a typical phenotype: downslanting palpebral ﬁssures,
coloboma of the lateral part of the lower lid, hypoplasia of
the mandible and the zygomatic bones, auricular malforma-
tions, hearing loss as well as, cleft lip and palate [4].
Treacher Collins syndrome is caused mainly by muta-
tions in the TCOF1 gene (Treacher Collins-Franceschetti 1),
which encodes a low complexity serine/alanine-rich nucleo-
lar phosphoprotein called Treacle.
Treacle participates in the formation of pre-rRNA by
interacting with UBF (upstream binding factor) and binding to
the UCE sequence (upstream control element) as well as
the main promoter region, causing DNA looping during
the transcription process [5]. Dauwerse et al. [6] detectedFig. 1 – Phenotype and analysis of the amplified fragment of exo
parents. (A) Phenotype of the patient with TCS. (B) Sequence anal
1, patient; 2, mother; 3, father; C, control. Arrow indicates locati
Ryc. 1 – Fenotyp i analiza amplifikowanego fragmentu eksonu 13 gen
(B) Analiza sekwencji amplifikowanego fragmentu eksonu 13 genu T
wskazuje lokalizację delecjimutations in genes encoding subunits of RNA polymerases
I and III (POLR1C and POLR1D) in patients with Treacher
Collins syndrome. That study conﬁrmed, that TCS is
a ribosomopathy and is genetically heterogeneous.
Most mutations identiﬁed in the TCOF1 gene are dele-
tions resulting in a truncated protein [7–13]. No genotype/
phenotype correlations have been found. We have identiﬁed
a novel mutation in exon 13 of the TCOF1 gene in a patient
with typical facial symptoms of Treacher Collins syndrome.
Materials and methods
A male infant was born at 38 weeks of gestation. At birth
his weight was 2720 g (3–10 centile), length was 55 cm (25–50
centile) and skull circumference was 35 cm (3–10 centile).
Physical and diagnostic examinations after birth revealed
asymmetrical facial abnormalities, including absence of the
right auditory canal, bilateral microtia, malar hypoplasia as
well as downslanting palpebral ﬁssures, bilateral partial
coloboma of the lateral part of the lower lids, sparse
eyelashes and mandibular hypoplasia (micro- and retrogna-
thia). Moreover, hearing loss was diagnosed. The externaln 13 of the TCOF1 gene in the patient with TCS and in his
ysis of the amplified fragment of exon 13 of the TCOF1 gene:
on of the deletion
u TCOF1 pacjenta z TCS i rodziców. (A) Fenotyp pacjenta z TCS.
COF1: 1 pacjent; 2, matka; 3, ojciec; C, kontrola. Strzałka
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3 and 5 months showed normal psychomotor and somatic
development (Fig. 1a).
DNA was isolated from peripheral blood leukocytes of the
patient and his healthy parents. Exons 1 through 27 of TCOF1,
including exon–intron borders, were ampliﬁed by PCR under
optimal conditions, using speciﬁc primers. The PCR products
were subjected to multitemperature single-stranded confor-
mation polymorphism (MSSCP) analysis at 5 8C, 15 8C and
25 8C, using the DNA Pointer Mutation Detection System. The
electrophoresis was followed by silver staining.
The PCR products were puriﬁed on the DNA GelOut
columns (A&A Biotechnology, Poland) followed by direct
sequencing with the use of a BigDye ver.3.0 dye terminator
cycle sequencing kit and speciﬁc primers. The dideoxy-
terminated fragments were identiﬁed by capillary gel-elec-
trophoresis based on the ABI 310 DNA Analysis System.
The MSSCP analysis of the ampliﬁed fragments of exon
13 of the TCOF1 gene demonstrated changes in the electrop-
horetic mobility in this patient, while the changes were not
observed in the patient's parents. In order to conﬁrm the
results obtained in MSSCP analysis a direct sequence
analysis was performed.
Results, discussion and conclusions
Sequence analysis demonstrated a novel, heterozygotic
c.1978delC mutation in exon 13 of TCOF1. In the case of the
patient's parents direct DNA sequencing showed normal
sequences (Fig. 1b).
A majority of mutations responsible for Treacher Collins
syndrome are localized in exons, mainly in the hot spots in
exons 10, 13, 15, 16, 23 and 24 [9].
The most commonly occurring mutations of the TCOF1
gene include deletions, which cause a shift of the reading
frame, formation of the termination codon and shortening
of the protein product. The next most common mutations
of the TCOF1 gene are insertions, the longest insertion
localized on exon 5 [14].
In the presented patient a novel, heterozygotic deletion
c.1978delC was detected in the TCOF1 gene. This mutation
was absent in the patient's parents which probably indicates
a de novo origin.
Analysis of the novel c.1978delC deletion with the use of
the OMIGA 2.0 system indicates that it causes a premature
termination of translation at 677aa, which results in the
formation of a protein product of the gene devoid of the
nuclear localization signal.
We believe that these ﬁndings will facilitate precise
diagnosis of the patient and will extend our knowledge on
the pathogenesis of TCS. Molecular diagnosis of TCS is
essential in prenatal and postnatal screening, being of great
importance for genetic counseling as well.
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